Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, China.
Eur J Cardiothorac Surg. 2021 Apr 29;59(4):799-806. doi: 10.1093/ejcts/ezaa371.
Nodal skip metastasis (NSM) is a common phenomenon in mid-thoracic oesophageal squamous cell carcinoma (MT-OSCC); however, the prognostic implications of NSM in patients with MT-OSCC remain unclear.
This retrospective study enrolled 300 patients with MT-OSCC who underwent radical oesophagectomy and who had pathologically confirmed lymph node metastasis from January 2014 to December 2016. The patients were divided into 2 groups according to the presence or absence of NSM. Propensity score matching was applied to minimize patient selection bias. The impact of NSM on overall survival (OS) was assessed by Kaplan-Meier and multiple Cox proportional hazards analyses. The median follow-up time was 57 months.
The NSM rate in the entire cohort was 22.0% (66/300). Pathological N (pN) stage (P < 0.001) and sex (P = 0.001) were identified as significant independent risk factors for NSM. NSM was more frequent in pN1 compared with pN2 patients (87.9% vs 12.1%, P < 0.001) and no NSM was found in pN3. NSM(+) patients had better prognoses than NSM(-) patients (Kaplan-Meier; 3-year OS, 62.1% vs 34.1%, P < 0.001). Propensity score matching produced 51 matched pairs, and the 3-year OS was still better in the NSM(+) compared with the NSM(-) group (66.7% vs 40.0%, P = 0.025). Multivariable Cox analysis confirmed NSM(+) as an independent factor favouring OS in patients with MT-OSCC.
NSM usually occurs at pN1 stage in patients with MT-OSCC, and is associated with a favourable prognosis.
跳跃性淋巴结转移(NSM)是胸中段食管鳞癌(MT-OSCC)的常见现象,但 NSM 对 MT-OSCC 患者的预后意义仍不清楚。
本回顾性研究纳入了 2014 年 1 月至 2016 年 12 月期间接受根治性食管切除术且病理证实有淋巴结转移的 300 例 MT-OSCC 患者。根据是否存在 NSM 将患者分为 2 组。应用倾向评分匹配以尽量减少患者选择偏倚。通过 Kaplan-Meier 和多 Cox 比例风险分析评估 NSM 对总生存(OS)的影响。中位随访时间为 57 个月。
整个队列的 NSM 率为 22.0%(66/300)。病理 N(pN)分期(P<0.001)和性别(P=0.001)被确定为 NSM 的显著独立危险因素。与 pN2 患者相比,pN1 患者的 NSM 更为常见(87.9% vs 12.1%,P<0.001),而 pN3 患者则没有 NSM。与 NSM(-)患者相比,NSM(+)患者的预后更好(Kaplan-Meier;3 年 OS,62.1% vs 34.1%,P<0.001)。倾向评分匹配产生了 51 对匹配对,NSM(+)组的 3 年 OS 仍优于 NSM(-)组(66.7% vs 40.0%,P=0.025)。多变量 Cox 分析证实,NSM(+)是 MT-OSCC 患者 OS 的独立有利因素。
NSM 通常发生在 MT-OSCC 的 pN1 期,与良好的预后相关。